<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">PRF</journal-id>
<journal-id journal-id-type="hwp">spprf</journal-id>
<journal-id journal-id-type="nlm-ta">Perfusion</journal-id>
<journal-title>Perfusion</journal-title>
<issn pub-type="ppub">0267-6591</issn>
<issn pub-type="epub">1477-111X</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0267659112474861</article-id>
<article-id pub-id-type="publisher-id">10.1177_0267659112474861</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Original Papers</subject></subj-group></article-categories>
<title-group>
<article-title>Effects of retrograde autologous priming on blood transfusion and clinical outcomes in adults: a meta-analysis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Sun</surname><given-names>P</given-names></name>
<xref ref-type="aff" rid="aff1-0267659112474861">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Ji</surname><given-names>B</given-names></name>
<xref ref-type="aff" rid="aff1-0267659112474861">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Sun</surname><given-names>Y</given-names></name>
<xref ref-type="aff" rid="aff1-0267659112474861">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Zhu</surname><given-names>X</given-names></name>
<xref ref-type="aff" rid="aff1-0267659112474861">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Liu</surname><given-names>J</given-names></name>
<xref ref-type="aff" rid="aff1-0267659112474861">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Long</surname><given-names>C</given-names></name>
<xref ref-type="aff" rid="aff1-0267659112474861">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Zheng</surname><given-names>Z</given-names></name>
<xref ref-type="aff" rid="aff2-0267659112474861">2</xref>
</contrib>
</contrib-group>
<aff id="aff1-0267659112474861">
<label>1</label>Department of Cardiopulmonary Bypass, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People’s Republic of China</aff>
<aff id="aff2-0267659112474861">
<label>2</label>Department of Cardiovascular Surgery, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People’s Republic of China</aff>
<author-notes>
<corresp id="corresp1-0267659112474861">Bingyang Ji Associate Professor of Cardiopulmonary Bypass Department of Cardiopulmonary Bypass State Key Laboratory of Cardiovascular Disease, Fuwai Hospital National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College 167 Beilishi Road Fuwai Dajie Xicheng qu Beijing 100037 People’s Republic of China 100037</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>5</month>
<year>2013</year>
</pub-date>
<volume>28</volume>
<issue>3</issue>
<fpage>238</fpage>
<lpage>243</lpage>
<permissions>
<copyright-statement>© The Author(s) 2013</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<sec id="section1-0267659112474861">
<title>Objective:</title>
<p>Reducing the priming volume is an effective means of decreasing hemodilution and blood transfusion during cardiopulmonary bypass (CPB). The patient’s own blood was used to replace the crystalloid in the CPB circuit by retrograde autologous priming (RAP) in order to decrease the priming volume. Therefore, we performed a meta-analysis to investigate whether RAP could reduce blood transfusion and improve clinical outcomes.</p>
</sec>
<sec id="section2-0267659112474861">
<title>Materials and Methods:</title>
<p>A comprehensive search was conducted for randomized, controlled trials (RCTs) exploring RAP in PubMed, Embase, The Cochrane Library, Google Scholar and Chinese literature databases (WanFang, WeiPu and CNKI). Clinical parameters and outcomes were focused on the lowest hematocrit (Hct) during CPB, the number of patients transfused blood intraoperatively, the number of patients transfused blood perioperatively, the number of blood units transfused, 24-hour chest tube drainage, hours to extubation, length of ICU stay, and length of hospital stay.</p>
</sec>
<sec id="section3-0267659112474861">
<title>Results:</title>
<p>Ten trials, with a total of 1123 patients, were included. The number of patients transfused blood intraoperatively (RR = 0.39, 95% CI = [0.29, 0.53], p&lt;0.00001, I<sup>2</sup> = 40%) and perioperatively (RR = 0.53, 95% CI = [0.43, 0.66], p&lt;0.00001, I<sup>2</sup> = 0%) and the number of blood units transfused (SMD = -0.53, 95% CI = [-0.73, -0.33], p&lt;0.00001, I<sup>2</sup> = 14%) were all significantly reduced in the RAP group. No differences in the hours to extubation (SMD = -0.11, 95% CI = [-0.33, 0.12], p=0.37, I<sup>2</sup> = 0%) and the length of ICU stay (SMD = -0.17, 95% CI = [-0.41, 0.08], p=0.18, I<sup>2</sup> = 0%) were observed between the two groups.</p>
</sec>
<sec id="section4-0267659112474861">
<title>Conclusion:</title>
<p>Compared to conventional priming, RAP could reduce transfusion in adults significantly, but had no effect on clinical outcomes, comparing to conventional priming. Further studies involving RAP are expected to investigate if this technique is beneficial to the patient.</p>
</sec>
</abstract>
<kwd-group>
<kwd>retrograde autologous priming</kwd>
<kwd>priming volume</kwd>
<kwd>blood transfusion</kwd>
<kwd>clinical outcomes</kwd>
<kwd>cardiopulmonary bypass</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section5-0267659112474861" sec-type="intro">
<title>Introduction</title>
<p>During cardiopulmonary bypass (CPB), cell salvage, ultrafiltration and reduction of priming volume are performed as blood-sparing approaches to reducing blood transfusion. In 1998, Rosengart et al. demonstrated a new means of reducing the priming volume by replacing the crystalloid in the CPB circuit with the patient’s own blood, which was called retrograde autologous priming (RAP).<sup><xref ref-type="bibr" rid="bibr1-0267659112474861">1</xref></sup> RAP was processed in three steps by drainage of the patient’s own blood via the arterial line, the venous reservoir, the oxygenator and the venous line, so that a fraction of the crystalloid priming volume was replaced by the circulating blood volume removed from the patient. The results showed that RAP reduced the priming and hemodilution, increased the intraoperative hematocrit (Hct) value and, moreover, reduced the number of patients requiring transfusion.</p>
<p>However, in a large sample-sized retrospective trial, the effects of RAP on the number of patients transfused was not apparent, with a non-significant reduction.<sup><xref ref-type="bibr" rid="bibr2-0267659112474861">2</xref></sup> In addition, it had been proven that the potential for complications of transfusion was strongly associated with increased mortality and postoperative morbidity.<sup><xref ref-type="bibr" rid="bibr3-0267659112474861">3</xref><xref ref-type="bibr" rid="bibr4-0267659112474861"/>–<xref ref-type="bibr" rid="bibr5-0267659112474861">5</xref></sup> Accordingly, we undertook a meta-analysis to evaluate the effects of RAP on blood transfusion and clinical outcomes, using a statistical tool to pool all the current data extracted from existing randomized controlled trials (RCTs).</p>
</sec>
<sec id="section6-0267659112474861" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="section7-0267659112474861">
<title>Study design</title>
<p>We compared the effects on transfusion and postoperative outcomes with using RAP or not using RAP, in adult cardiac surgery. RAP was defined as a technique to replace the crystalloid fluid in the CPB circuit, arterial filter, venous reservoir and oxygenator to a collection bag by draining the patient’s own blood before the initiation of bypass, for the purpose of reducing priming volume. The present plan was done according to PRISMA guidelines.<sup><xref ref-type="bibr" rid="bibr6-0267659112474861">6</xref></sup></p>
</sec>
<sec id="section8-0267659112474861">
<title>Search strategy and selection criteria</title>
<p>We searched for RCTs on RAP, comprehensively, in PubMed, Embase, The Cochrane Library, Google Scholar and Chinese literature databases (WanFang, WeiPu and CNKI). The keywords we used during the search procedure consisted of “retrograde autologous priming”, “cardiac surgery”, “cardiopulmonary bypass”, “extracorporeal circulation”, “prime” and “priming”. No language, publication date or publication status restrictions were imposed. RCTs comparing the effects on transfusion and postoperative outcomes in adult cardiac surgery due to the application or not of RAP were included. We excluded the studies about neonates, infants, children and combinations of other interventions that could influence priming volume. Titles, abstracts and full texts were reviewed by the investigator (PS) to establish whether they met the inclusion criteria. The whole search procedure was checked by the principal of this study (BJ). Included RCTs were selected and then data were extracted. The Jadad Score<sup><xref ref-type="bibr" rid="bibr7-0267659112474861">7</xref></sup> was used to assess the quality of the included studies.</p>
</sec>
<sec id="section9-0267659112474861">
<title>Statistical analysis</title>
<p>The effect size of dichotomous variables was expressed as relative risk (RR) and 95% confidence interval (CI) while the effect of continuous variables was expressed as standardized mean difference (SMD) and 95% CI. The type of effect model depended on the heterogeneity between studies, which was evaluated by the I<sup>2</sup> and Q test. A fixed effect model was chosen when the heterogeneity was mild or moderate (I<sup>2</sup>&lt;50%, p&gt;0.1). Otherwise, a random effect model was chosen. The statistical analysis was done using RevMan5.1 (version 5.1.Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011).</p>
</sec></sec>
<sec id="section10-0267659112474861" sec-type="results">
<title>Results</title>
<p>The search of PubMed, Embase, The Cochrane Library, Google Scholar and Chinese literature databases produced a total of 1953 papers containing the keywords. Of the 1953 potentially relevant articles initially screened, 58 trials with the application of RAP were obtained through reviewing titles and abstracts. After reading the full texts, eight trials about non-adult cardiac surgery, two trials with no relevant clinical endpoints, six trials combined with other interventions (e.g., acute normovolemic hemodilution, intraoperative autologous donation, shortening circuits, etc.) and 32 non-RCTs were excluded. Finally, 10 RCTs met the inclusion criteria and were included in the meta-analysis (<xref ref-type="fig" rid="fig1-0267659112474861">Figure 1</xref>), with a total of 1123 patients.<sup><xref ref-type="bibr" rid="bibr1-0267659112474861">1</xref>,<xref ref-type="bibr" rid="bibr8-0267659112474861">8</xref><xref ref-type="bibr" rid="bibr9-0267659112474861"/><xref ref-type="bibr" rid="bibr10-0267659112474861"/><xref ref-type="bibr" rid="bibr11-0267659112474861"/><xref ref-type="bibr" rid="bibr12-0267659112474861"/><xref ref-type="bibr" rid="bibr13-0267659112474861"/><xref ref-type="bibr" rid="bibr14-0267659112474861"/><xref ref-type="bibr" rid="bibr15-0267659112474861"/>–<xref ref-type="bibr" rid="bibr16-0267659112474861">16</xref></sup> The basic characteristics of the included RCTs were extracted and recorded in the form of a table, with a 1.6 mean Jadad Score (range 1-3) (<xref ref-type="table" rid="table1-0267659112474861">Table 1</xref>).</p>
<fig id="fig1-0267659112474861" position="float">
<label>Figure 1.</label>
<caption>
<p>Trial profile.</p>
</caption>
<graphic xlink:href="10.1177_0267659112474861-fig1.tif"/></fig>
<table-wrap id="table1-0267659112474861" position="float">
<label>Table 1.</label>
<caption>
<p>Characteristics of included trials.</p>
</caption>
<graphic alternate-form-of="table1-0267659112474861" xlink:href="10.1177_0267659112474861-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="left"/>
<col align="left"/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Author</th>
<th align="left">Year</th>
<th align="left">Sample size (RAP/C)</th>
<th align="left">Transfusion protocol<break/>(Intra-op/Post-op Hct)</th>
<th align="left">Priming volume (mL) (RAP/C)</th>
<th align="left">Jadad Score</th>
</tr>
</thead>
<tbody>
<tr>
<td>Rosengart et al.<sup><xref ref-type="bibr" rid="bibr1-0267659112474861">1</xref></sup></td>
<td>1998</td>
<td>30/30</td>
<td>16%/23%</td>
<td>520/1400</td>
<td>2</td>
</tr>
<tr>
<td>Shapira et al.<sup><xref ref-type="bibr" rid="bibr8-0267659112474861">8</xref></sup></td>
<td>1998</td>
<td>57/57</td>
<td>20%/25%</td>
<td>653/1400</td>
<td>1</td>
</tr>
<tr>
<td>Rousou et al.<sup><xref ref-type="bibr" rid="bibr9-0267659112474861">9</xref></sup></td>
<td>1999</td>
<td>97/78</td>
<td>20%/20%</td>
<td>498/1500</td>
<td>2</td>
</tr>
<tr>
<td>Balachandran et al.<sup><xref ref-type="bibr" rid="bibr10-0267659112474861">10</xref></sup></td>
<td>2002</td>
<td>51/49</td>
<td>18%/24%</td>
<td>891/1700</td>
<td>2</td>
</tr>
<tr>
<td>Eising et al.<sup><xref ref-type="bibr" rid="bibr11-0267659112474861">11</xref></sup></td>
<td>2003</td>
<td>10/10</td>
<td>n.r.</td>
<td>395/1602</td>
<td>2</td>
</tr>
<tr>
<td>Sobieski et al.<sup><xref ref-type="bibr" rid="bibr12-0267659112474861">12</xref></sup></td>
<td>2005</td>
<td>115/107</td>
<td>20% during hypothermia or 24% while rewarming / n.r.</td>
<td>622/1517</td>
<td>1</td>
</tr>
<tr>
<td>Hou et al.<sup><xref ref-type="bibr" rid="bibr13-0267659112474861">13</xref></sup></td>
<td>2009</td>
<td>60/60</td>
<td>24%/27%</td>
<td>450/1185</td>
<td>3</td>
</tr>
<tr>
<td>Reges et al.<sup><xref ref-type="bibr" rid="bibr14-0267659112474861">14</xref></sup></td>
<td>2011</td>
<td>27/35</td>
<td>n.r.</td>
<td>n.r.</td>
<td>1</td>
</tr>
<tr>
<td>Yang et al.<sup><xref ref-type="bibr" rid="bibr15-0267659112474861">15</xref></sup></td>
<td>2010</td>
<td>105/105</td>
<td>n.r.</td>
<td>760/1563</td>
<td>1</td>
</tr>
<tr>
<td>Zhao et al.<sup><xref ref-type="bibr" rid="bibr16-0267659112474861">16</xref></sup></td>
<td>2010</td>
<td>20/20</td>
<td>23%/27%</td>
<td>n.r.</td>
<td>1</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0267659112474861"><p>C: control group; Intra-op: intraoperative; Post-op: postoperative; n.r.: study did not report.</p></fn>
</table-wrap-foot></table-wrap>
<sec id="section11-0267659112474861">
<title>Number of patients transfused blood intraoperatively, perioperatively and number of blood units transfused</title>
<p>The number of patients transfused blood intraoperatively was reported in seven trials, with a total of 151 in 779 patients. The size effect showed a significant reduction in the RAP group (RR=0.39, 95% CI = [0.29, 0.53], p&lt;0.00001), with moderate heterogeneity (<italic>p</italic>=0.12, I<sup>2</sup> = 40%) (<xref ref-type="fig" rid="fig2-0267659112474861">Figure 2</xref>). The number of patients transfused blood perioperatively was reported in four trials, with a total of 192 in 394 patients. The size effect showed a significant reduction in the RAP group (RR = 0.53, 95% CI = [0.43, 0.66], <italic>p</italic>&lt;0.00001), with mild heterogeneity (p=0.52, I<sup>2</sup> = 0%) (<xref ref-type="fig" rid="fig3-0267659112474861">Figure 3</xref>). The number of blood units transfused was reported in five trials, with a total of 414 patients. The size effect showed a significant reduction in the RAP group (SMD = -0.53, 95% CI = [-0.73, -0.33], p&lt;0.00001), with mild heterogeneity (p=0.32, I<sup>2</sup> = 14%) (<xref ref-type="fig" rid="fig4-0267659112474861">Figure 4</xref>).</p>
<fig id="fig2-0267659112474861" position="float">
<label>Figure 2.</label>
<caption>
<p>Number of patients transfused blood intraoperatively.</p>
</caption>
<graphic xlink:href="10.1177_0267659112474861-fig2.tif"/></fig>
<fig id="fig3-0267659112474861" position="float">
<label>Figure 3.</label>
<caption>
<p>Number of patients transfused blood perioperatively.</p>
</caption>
<graphic xlink:href="10.1177_0267659112474861-fig3.tif"/></fig>
<fig id="fig4-0267659112474861" position="float">
<label>Figure 4.</label>
<caption>
<p>Number of blood units transfused (unit/patient transfused).</p>
</caption>
<graphic xlink:href="10.1177_0267659112474861-fig4.tif"/></fig>
</sec>
<sec id="section12-0267659112474861">
<title>Hours to extubation and length of ICU stay</title>
<p>The hours to extubation was reported in four trials, with a total of 294 patients. The size effect showed no significant statistical differences in the RAP and control groups (SMD = -0.11, 95% CI = [-0.33, 0.12], p=0.37), with mild heterogeneity (p=0.90, I<sup>2</sup> = 0%) (<xref ref-type="fig" rid="fig5-0267659112474861">Figure 5</xref>). The length of ICU stay was reported in three trials, with a total of 254 patients. The size effect showed no significant statistical differences in the RAP and control groups (SMD = -0.17, 95% CI = [-0.41, 0.08], p=0.18), with mild heterogeneity (p=0.84, I<sup>2</sup> = 0%) (<xref ref-type="fig" rid="fig6-0267659112474861">Figure 6</xref>).</p>
<fig id="fig5-0267659112474861" position="float">
<label>Figure 5.</label>
<caption>
<p>Hours to extubation (hour).</p>
</caption>
<graphic xlink:href="10.1177_0267659112474861-fig5.tif"/></fig>
<fig id="fig6-0267659112474861" position="float">
<label>Figure 6.</label>
<caption>
<p>Length of ICU stay (hour).</p>
</caption>
<graphic xlink:href="10.1177_0267659112474861-fig6.tif"/></fig>
</sec>
<sec id="section13-0267659112474861">
<title>Lowest Hct during CPB, 24-hour chest tube drainage and length of hospital stay</title>
<p>There were statistical differences between the lowest Hct during CPB (SMD = 1.75, 95% CI = [0.90, 2.61], p&lt;0.0001, I<sup>2</sup> = 95%) and 24-hour chest tube drainage (SMD = -0.33, 95% CI = [-0.52, -0.14], p=0.0005, I<sup>2</sup> = 74%) in the RAP and control groups while the length of total hospital stay (SMD = -0.14, 95% CI = [-0.39, 0.11], p=0.28, I<sup>2</sup> = 78%) was not apparently influenced. With significant heterogeneity (I<sup>2</sup>&gt;50%), the effects of RAP could not be evaluated.</p>
</sec></sec>
<sec id="section14-0267659112474861" sec-type="discussion">
<title>Discussion</title>
<p>Blood transfusion is an effective means of increasing hemoglobin and coagulation factors in cardiac surgery, but it is also associated with infections, renal failure, lung injury, prolonged ventilation, low cardiac output, prolonged hospital stay and even death.<sup><xref ref-type="bibr" rid="bibr3-0267659112474861">3</xref><xref ref-type="bibr" rid="bibr4-0267659112474861"/>–<xref ref-type="bibr" rid="bibr5-0267659112474861">5</xref></sup> Moreover, the complications caused by transfusion could further increase the patient’s cost in hospital to achieve better results.<sup><xref ref-type="bibr" rid="bibr17-0267659112474861">17</xref></sup> Therefore, how to reduce transfusion is a key point.</p>
<p>In 2009, some investigators had performed a meta-analysis to evaluate the effects of RAP on the patient’s transfusion during CPB.<sup><xref ref-type="bibr" rid="bibr18-0267659112474861">18</xref></sup> They included six trials and drew the conclusion that RAP could reduce the number of patients transfused and blood units used, but they did not analyze the effects of RAP on the patient’s clinical outcomes. In our meta-analysis, covering the six trials included in the former meta-analysis, we updated the four trials most recently published. We confirmed that RAP could reduce the patient’s perioperative transfusion. Furthermore, we found no statistical differences in the number of hours to extubation, the length of ICU stay and the length of hospital stay between the two groups. It has been proved that a reduction of a patient’s transfusion could decrease the patient’s short-term and long-term complications after cardiac procedures.<sup><xref ref-type="bibr" rid="bibr3-0267659112474861">3</xref><xref ref-type="bibr" rid="bibr4-0267659112474861"/>–<xref ref-type="bibr" rid="bibr5-0267659112474861">5</xref></sup> Contradictorily, based on the results that RAP could reduce the patients’ perioperative transfusions, we failed to prove the benefits of RAP on the patients’ clinical outcomes. The probable reason for this phenomenon might be related to the small sample size of the trials included in the study. Therefore, we could not discover the positive effects of RAP on the patients’ clinical outcomes.</p>
<p>The severe heterogeneity of the lowest Hct during CPB, the 24-hour chest tube drainage and the length of total hospital stay between the two groups might be caused by the different steps and vasopressor agents used during the RAP process and the different inclusion and exclusion criteria. The mean Jadad Score of the included ten trials in this meta-analysis was only 1.6, with a lack of large-scaled, double-blind RCTs, which revealed that the trials in which RAP was used as the only intervention were still less. This may be caused by the following limitations in the application of RAP: 1) <italic>The possibility of hemodynamic instability during the RAP process</italic>. The patient’s own blood was withdrawn to prime the CPB circuit, which could cause the relative hypovolemia and hypotension. The blood pressure could be maintained with vasopressor agents, as necessary. At what level the minimum blood pressure should be maintained is still beyond consensus. 2) <italic>The hypovolemia caused by RAP</italic>. The venous reservoir volume during CPB was lower in the RAP group than in the control group, which might lead to insufficient venous gaseous microemboli de-airing and increase the risks of letting air in. A safety threshold of the venous reservoir volume was recommended to be maintained above 400 mL.<sup><xref ref-type="bibr" rid="bibr1-0267659112474861">1</xref></sup> 3) <italic>The higher Hct value during CPB</italic>. Reduction of the priming volume caused a higher Hct, which might have increased blood destruction.</p>
<p>In a large sample-sized retrospective trial, the effects of RAP on the number of patients transfused was not apparent, with a non-significant reduction.<sup><xref ref-type="bibr" rid="bibr2-0267659112474861">2</xref></sup> Therefore, instead of the application of only RAP, a combination of RAP and other blood conservation techniques could be undertaken to achieve the optimal effects of blood conservation and improve the patients’ clinical outcomes in a comprehensive evaluation of every patient. It was reported that, by the combination of RAP and other blood sparing approaches, cardiac surgery was performed successfully on Jehovah’s Witnesses who refused any blood transfusion.<sup><xref ref-type="bibr" rid="bibr19-0267659112474861">19</xref>,<xref ref-type="bibr" rid="bibr20-0267659112474861">20</xref></sup></p>
<p>The combination of RAP and acute normovolemic hemodilution (ANH) or intraoperative autologous donation (IAD) could maintain the patient’s circulating volume and Hct value at an optimal level, with the purpose of reducing blood destruction and transfusion, improving clinical outcomes.<sup><xref ref-type="bibr" rid="bibr21-0267659112474861">21</xref>,<xref ref-type="bibr" rid="bibr22-0267659112474861">22</xref></sup> By changing the position of the pump head, venous reservoir and oxygenator closer to the patient and using shortened and downsized CPB circuits, better effects on blood conservation could be achieved.<sup><xref ref-type="bibr" rid="bibr23-0267659112474861">23</xref>,<xref ref-type="bibr" rid="bibr24-0267659112474861">24</xref></sup> The remote-mounted CPB systems and downsized circuits might have a bad influence on the gravity-dependent venous drainage; however, a combination with vacuum-assisted venous drainage (VAVD) could solve this problem to provide adequate venous drainage.<sup><xref ref-type="bibr" rid="bibr25-0267659112474861">25</xref>,<xref ref-type="bibr" rid="bibr26-0267659112474861">26</xref></sup> It was reported that the combination of RAP and minimal extracorporeal circulation (MECC) also achieved the aim of blood conservation.<sup><xref ref-type="bibr" rid="bibr27-0267659112474861">27</xref><xref ref-type="bibr" rid="bibr28-0267659112474861"/>–<xref ref-type="bibr" rid="bibr29-0267659112474861">29</xref></sup></p>
</sec>
<sec id="section15-0267659112474861" sec-type="conclusions">
<title>Conclusion</title>
<p>This meta-analysis showed that the application of RAP could reduce perioperative transfusion requirements in adults significantly; however, no benefits on the patient’s clinical outcomes were observed according to the present trials, with probable reasons which could be related to the low Jadad Score and the small sample size of the included trials. Further large-scale, randomized, controlled, double-blind trials exploring RAP are needed to comprehensively evaluate the clinical effects.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict">
<label>Conflicts of Interest</label>
<p>The authors declare that there are no conflicts of interest.</p></fn>
<fn fn-type="financial-disclosure">
<label>Funding</label>
<p>This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.</p></fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0267659112474861">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rosengart</surname><given-names>TK</given-names></name>
<name><surname>DeBois</surname><given-names>W</given-names></name>
<name><surname>O’Hara</surname><given-names>M</given-names></name>
<etal/>
</person-group>. <article-title>Retrograde autologous priming for cardiopulmonary bypass: a safe and effective means of decreasing hemodilution and transfusion requirements</article-title>. <source>J Thorac Cardiovasc Surg</source> <year>1998</year>; <volume>115</volume>: <fpage>426</fpage>–<lpage>439</lpage>.</citation>
</ref>
<ref id="bibr2-0267659112474861">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Murphy</surname><given-names>GS</given-names></name>
<name><surname>Szokol</surname><given-names>JW</given-names></name>
<name><surname>Nitsun</surname><given-names>M</given-names></name>
<etal/>
</person-group>. <article-title>The failure of retrograde autologous priming of the cardiopulmonary bypass circuit to reduce blood use after cardiac surgical procedures</article-title>. <source>Anesth Analg</source> <year>2004</year>; <volume>98</volume>: <fpage>1201</fpage>–<lpage>1207</lpage>.</citation>
</ref>
<ref id="bibr3-0267659112474861">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ferraris</surname><given-names>VA</given-names></name>
<name><surname>Brown</surname><given-names>JR</given-names></name>
<name><surname>Despotis</surname><given-names>GJ</given-names></name>
<etal/>
</person-group>. <article-title>2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines</article-title>. <source>Ann Thorac Surg</source> <year>2011</year>; <volume>91</volume>: <fpage>944</fpage>–<lpage>982</lpage>.</citation>
</ref>
<ref id="bibr4-0267659112474861">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Koch</surname><given-names>CG</given-names></name>
<name><surname>Li</surname><given-names>L</given-names></name>
<name><surname>Sessler</surname><given-names>DI</given-names></name>
<etal/>
</person-group>. <article-title>Duration of red-cell storage and complications after cardiac surgery</article-title>. <source>N Engl J Med</source> <year>2008</year>; <volume>358</volume>: <fpage>1229</fpage>–<lpage>1239</lpage>.</citation>
</ref>
<ref id="bibr5-0267659112474861">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Engoren</surname><given-names>MC</given-names></name>
<name><surname>Habib</surname><given-names>RH</given-names></name>
<name><surname>Zacharias</surname><given-names>A</given-names></name>
<name><surname>Schwann</surname><given-names>TA</given-names></name>
<name><surname>Riordan</surname><given-names>CJ</given-names></name>
<name><surname>Durham</surname><given-names>SJ.</given-names></name>
</person-group> <article-title>Effect of blood transfusion on long-term survival after cardiac operation</article-title>. <source>Ann Thorac Surg</source> <year>2002</year>; <volume>74</volume>: <fpage>1180</fpage>–<lpage>1186</lpage>.</citation>
</ref>
<ref id="bibr6-0267659112474861">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Moher</surname><given-names>D</given-names></name>
<name><surname>Liberati</surname><given-names>A</given-names></name>
<name><surname>Tetzlaff</surname><given-names>J</given-names></name>
<name><surname>Altman</surname><given-names>DG</given-names></name>
</person-group>; <collab>PRISMA Group</collab>. <article-title>Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement</article-title>. <source>PLoS Med</source> <year>2009</year>; <volume>6</volume>: <fpage>e1000097</fpage>.</citation>
</ref>
<ref id="bibr7-0267659112474861">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jadad</surname><given-names>AR</given-names></name>
<name><surname>Moore</surname><given-names>RA</given-names></name>
<name><surname>Carroll</surname><given-names>D</given-names></name>
<etal/>
</person-group>. <article-title>Assessing the quality of reports of randomized clinical trials: is blinding necessary?</article-title> <source>Control Clin Trials</source> <year>1996</year>; <volume>17</volume>: <fpage>1</fpage>–<lpage>12</lpage>.</citation>
</ref>
<ref id="bibr8-0267659112474861">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Shapira</surname><given-names>OM</given-names></name>
<name><surname>Aldea</surname><given-names>GS</given-names></name>
<name><surname>Treanor</surname><given-names>PR</given-names></name>
<etal/>
</person-group>. <article-title>Reduction of allogeneic blood transfusions after open heart operations by lowering cardiopulmonary bypass prime volume</article-title>. <source>Ann Thorac Surg</source> <year>1998</year>; <volume>65</volume>: <fpage>724</fpage>–<lpage>730</lpage>.</citation>
</ref>
<ref id="bibr9-0267659112474861">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rousou</surname><given-names>JA</given-names></name>
<name><surname>Engelman</surname><given-names>RM</given-names></name>
<name><surname>Flack</surname><given-names>JE</given-names><suffix>3rd</suffix></name>
<name><surname>Deaton</surname><given-names>DW</given-names></name>
<name><surname>Garb</surname><given-names>JL</given-names></name>
<name><surname>Owen</surname><given-names>SG</given-names></name>
</person-group>. <article-title>The ‘primeless pump’: a novel technique for intraoperative blood conservation</article-title>. <source>Cardiovasc Surg</source> <year>1999</year>; <volume>7</volume>: <fpage>228</fpage>–<lpage>235</lpage>.</citation>
</ref>
<ref id="bibr10-0267659112474861">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Balachandran</surname><given-names>S</given-names></name>
<name><surname>Cross</surname><given-names>MH</given-names></name>
<name><surname>Karthikeyan</surname><given-names>S</given-names></name>
<name><surname>Mulpur</surname><given-names>A</given-names></name>
<name><surname>Hansbro</surname><given-names>SD</given-names></name>
<name><surname>Hobson</surname><given-names>P.</given-names></name>
</person-group> <article-title>Retrograde autologous priming of the cardiopulmonary bypass circuit reduces blood transfusion after coronary artery surgery</article-title>. <source>Ann Thorac Surg</source> <year>2002</year>; <volume>73</volume>: <fpage>1912</fpage>–<lpage>1918</lpage>.</citation>
</ref>
<ref id="bibr11-0267659112474861">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Eising</surname><given-names>GP</given-names></name>
<name><surname>Pfauder</surname><given-names>M</given-names></name>
<name><surname>Niemeyer</surname><given-names>M</given-names></name>
<etal/>
</person-group>. <article-title>Retrograde autologous priming: is it useful in elective on-pump coronary artery bypass surgery?</article-title> <source>Ann Thorac Surg</source> <year>2003</year>, <volume>75</volume>: <fpage>23</fpage>–<lpage>27</lpage>.</citation>
</ref>
<ref id="bibr12-0267659112474861">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sobieski</surname><given-names>MA</given-names></name>
<name><surname>Slaughter</surname><given-names>MS</given-names></name>
<name><surname>Hart</surname><given-names>DE</given-names></name>
<name><surname>Pappas</surname><given-names>PS</given-names></name>
<name><surname>Tatooles</surname><given-names>AJ.</given-names></name>
</person-group> <article-title>Prospective study on cardiopulmonary bypass prime reduction and its effect on intraoperative blood product and hemoconcentrator use</article-title>. <source>Perfusion</source> <year>2005</year>, <volume>20</volume>: <fpage>31</fpage>–<lpage>37</lpage>.</citation>
</ref>
<ref id="bibr13-0267659112474861">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hou</surname><given-names>X</given-names></name>
<name><surname>Yang</surname><given-names>F</given-names></name>
<name><surname>Liu</surname><given-names>R</given-names></name>
<etal/>
</person-group>. <article-title>Retrograde autologous priming of the cardiopulmonary bypass circuit reduces blood transfusion in small adults: a prospective, randomized trial</article-title>. <source>Eur J Anaesthesiol</source> <year>2009</year>; <volume>26</volume>: <fpage>1061</fpage>–<lpage>1066</lpage>.</citation>
</ref>
<ref id="bibr14-0267659112474861">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Reges</surname><given-names>RV</given-names></name>
<name><surname>Vicente</surname><given-names>WVA</given-names></name>
<name><surname>Rodrigues</surname><given-names>AJ</given-names></name>
<etal/>
</person-group>. <article-title>Retrograde autologous priming in cardiopulmonary bypass in adult patients: effects on blood transfusion and hemodilution</article-title>. <source>Rev Bras Cir Cardiovasc</source> <year>2011</year>; <volume>26</volume>: <fpage>609</fpage>–<lpage>616</lpage>.</citation>
</ref>
<ref id="bibr15-0267659112474861">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yang</surname><given-names>J</given-names></name>
<name><surname>He</surname><given-names>M</given-names></name>
<name><surname>Zhao</surname><given-names>Y</given-names></name>
<name><surname>Dong</surname><given-names>P.</given-names></name>
</person-group> <article-title>Application of retrograde autologous priming in cardiopulmonary bypass</article-title>. [Chinese] <source>Chin J ECC</source> <year>2010</year>; <volume>8</volume>: <fpage>83</fpage>–<lpage>85</lpage>.</citation>
</ref>
<ref id="bibr16-0267659112474861">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zhao</surname><given-names>Y</given-names></name>
<name><surname>Yang</surname><given-names>J</given-names></name>
<name><surname>Dong</surname><given-names>P.</given-names></name>
</person-group> <article-title>Effects of retrograde autologous priming on blood components in adults single valve replacement</article-title>. [Chinese] <source>Chin J ECC</source> <year>2010</year>; <volume>8</volume>: <fpage>86</fpage>–<lpage>89</lpage>.</citation>
</ref>
<ref id="bibr17-0267659112474861">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Stokes</surname><given-names>ME</given-names></name>
<name><surname>Ye</surname><given-names>X</given-names></name>
<name><surname>Shah</surname><given-names>M</given-names></name>
<etal/>
</person-group>. <article-title>Impact of bleeding-related complications and/or blood product transfusions on hospital costs in inpatient surgical patients</article-title>. <source>BMC Health Serv Res</source> <year>2011</year>; <volume>11</volume>: <fpage>135</fpage>.</citation>
</ref>
<ref id="bibr18-0267659112474861">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Saczkowski</surname><given-names>R</given-names></name>
<name><surname>Bernier</surname><given-names>PL</given-names></name>
<name><surname>Tchervenkov</surname><given-names>CI</given-names></name>
<name><surname>Arellano</surname><given-names>R.</given-names></name>
</person-group> <article-title>Retrograde autologous priming and allogeneic blood transfusions: a meta-analysis</article-title>. <source>Interact Cardiovasc Thorac Surg</source> <year>2008</year>; <volume>8</volume>: <fpage>373</fpage>–<lpage>376</lpage>.</citation>
</ref>
<ref id="bibr19-0267659112474861">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Brest van Kempen</surname><given-names>AB</given-names></name>
<name><surname>Gasiorek</surname><given-names>JM</given-names></name>
<name><surname>Bloemendaal</surname><given-names>K</given-names></name>
<name><surname>Storm van Leeuwen</surname><given-names>RP</given-names></name>
<name><surname>Bulder</surname><given-names>ER.</given-names></name>
</person-group> <article-title>Low-prime perfusion circuit and autologous priming in CABG surgery on a Jehovah’s Witness: a case report</article-title>. <source>Perfusion</source> <year>2002</year>; <volume>17</volume>: <fpage>69</fpage>–<lpage>72</lpage>.</citation>
</ref>
<ref id="bibr20-0267659112474861">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sutton</surname><given-names>SW</given-names></name>
<name><surname>Duncan</surname><given-names>MA</given-names></name>
<name><surname>Chase</surname><given-names>VA</given-names></name>
<name><surname>Cheung</surname><given-names>EH</given-names></name>
<name><surname>Hamman</surname><given-names>BL.</given-names></name>
</person-group> <article-title>Leukocyte filtration and miniature perfusion during arrested heart CABG on a Jehovah’s Witness patient</article-title>. <source>Perfusion</source> <year>2004</year>; <volume>19</volume>: <fpage>375</fpage>–<lpage>379</lpage>.</citation>
</ref>
<ref id="bibr21-0267659112474861">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Srinivas</surname><given-names>K</given-names></name>
<name><surname>Singh</surname><given-names>K.</given-names></name>
</person-group> <article-title>Combination of autologous transfusion and retrograde autologous priming decreases blood requirements</article-title>. <source>Ann Card Anaesth</source> <year>2001</year>; <volume>4</volume>: <fpage>28</fpage>–<lpage>32</lpage>.</citation>
</ref>
<ref id="bibr22-0267659112474861">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Saxena</surname><given-names>P</given-names></name>
<name><surname>Saxena</surname><given-names>N</given-names></name>
<name><surname>Jain</surname><given-names>A</given-names></name>
<name><surname>Sharma</surname><given-names>VK.</given-names></name>
</person-group> <article-title>Intraoperative autologous blood donation and retrograde autologous priming for cardiopulmonary bypass: a safe and effective technique for blood conservation</article-title>. <source>Ann Card Anaesth</source> <year>2003</year>; <volume>6</volume>: <fpage>47</fpage>–<lpage>51</lpage>.</citation>
</ref>
<ref id="bibr23-0267659112474861">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zelinka</surname><given-names>ES</given-names></name>
<name><surname>Ryan</surname><given-names>P</given-names></name>
<name><surname>McDonald</surname><given-names>J</given-names></name>
<name><surname>Larson</surname><given-names>J.</given-names></name>
</person-group> <article-title>Retrograde autologous prime with shortened bypass circuits decreases blood transfusion in high-risk coronary artery surgery patients</article-title>. <source>J Extra Corpor Technol</source> <year>2004</year>; <volume>36</volume>: <fpage>343</fpage>–<lpage>347</lpage>.</citation>
</ref>
<ref id="bibr24-0267659112474861">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kulat</surname><given-names>B</given-names></name>
<name><surname>Zingle</surname><given-names>N.</given-names></name>
</person-group> <article-title>Optimizing circuit design using a remote-mounted perfusion system</article-title>. <source>J Extra Corpor Technol</source> <year>2009</year>; <volume>41</volume>: <fpage>28</fpage>–<lpage>31</lpage>.</citation>
</ref>
<ref id="bibr25-0267659112474861">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pappalardo</surname><given-names>F</given-names></name>
<name><surname>Corno</surname><given-names>C</given-names></name>
<name><surname>Franco</surname><given-names>A</given-names></name>
<etal/>
</person-group>. <article-title>Reduction of hemodilution in small adults undergoing open heart surgery: a prospective, randomized trial</article-title>. <source>Perfusion</source> <year>2007</year>; <volume>22</volume>: <fpage>317</fpage>–<lpage>322</lpage>.</citation>
</ref>
<ref id="bibr26-0267659112474861">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Durandy</surname><given-names>Y.</given-names></name>
</person-group> <article-title>The impact of vacuum-assisted venous drainage and miniaturized bypass circuits on blood transfusion in pediatric cardiac surgery</article-title>. <source>ASAIO J</source> <year>2009</year>; <volume>55</volume>: <fpage>117</fpage>–<lpage>120</lpage>.</citation>
</ref>
<ref id="bibr27-0267659112474861">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dreizler</surname><given-names>T</given-names></name>
<name><surname>Herbrechtsmeier</surname><given-names>T</given-names></name>
<name><surname>Born</surname><given-names>F</given-names></name>
<etal/>
</person-group>. <article-title>Effects of optimized bypass systems with retrograde autologous priming during extracorporeal circulation in high-risk patients</article-title>. [German] <source>Kardiotechnik</source> <year>2010</year>; <volume>19</volume>: <fpage>6</fpage>–<lpage>10</lpage>.</citation>
</ref>
<ref id="bibr28-0267659112474861">
<label>28.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lisy</surname><given-names>M</given-names></name>
<name><surname>Schmid</surname><given-names>E</given-names></name>
<name><surname>Nagy</surname><given-names>Z</given-names></name>
<etal/>
</person-group>. <article-title>On-pump aortic valve replacement without allogeneic blood product transfusion</article-title>. <source>Thorac Cardiovasc Surg</source> <year>2011</year>; <volume>59</volume>: <supplement>SUPPL. 1</supplement>.</citation>
</ref>
<ref id="bibr29-0267659112474861">
<label>29.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lisy</surname><given-names>M</given-names></name>
<name><surname>Schmid</surname><given-names>E</given-names></name>
<name><surname>Schmid</surname><given-names>R</given-names></name>
<etal/>
</person-group>. <article-title>On-pump coronary artery bypass surgery without allogenic blood product transfusion</article-title>. <source>Thorac Cardiovasc Surg</source> <year>2011</year>; <volume>58</volume>: <supplement>SUPPL. 1</supplement>.</citation>
</ref></ref-list>
</back>
</article>